Clin2
NCT07729293Likely a fitNot yet recruiting

A new add-on treatment for H. pylori infection

Helicobacter Pylori InfectionDyspepsiaGastrointestinal Adverse Effects

Treatments studied

Part of Digestive system, Infections clinical trials.

This study tests a new treatment called Pylori Duo, used along with standard care, to help get rid of H. pylori bacteria in the stomach and stop it from coming back. It may be a good option if you are newly diagnosed and haven't been treated before.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have a confirmed H. pylori infection (a stomach bacteria) shown by a breath test and a stomach biopsy.
  • You have never been treated for H. pylori before.
  • You are generally healthy — no serious liver, kidney, heart, lung, thyroid, or immune problems, and no active cancer.
  • You are not pregnant or breastfeeding and will use birth control during the study.
  • You have not taken antibiotics, acid reducers, or bismuth products in the last 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07139366Recruiting· Phase 4
Probiotic plus bismuth combo for stubborn H. pylori

This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.

Xi'an, Shaanxi
NCT07827170Not yet recruiting
Probiotics with standard H. pylori treatment

This study tests whether adding a probiotic (a healthy bacteria supplement) to the standard four-drug treatment for H. pylori infection helps get rid of the bacteria better and with fewer side effects. It may help make your treatment more effective and easier to tolerate.

Hanoi
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT06929962Recruiting· Phase 4
VA dual sequential therapy for H. pylori gastritis

This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.

Nanjing, Jiangsu
NCT07624422Not yet recruiting· Phase 4
Helicobacter pylori infection treatment study

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Damascus
NCT06200779Not yet recruiting· Phase 4
Personalized versus standard treatment for H. pylori infection

This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.

Porto, Porto District

Hear when a new Helicobacter Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.